← Open Payments lookup

JENNIFER CHOW: Open Payments

NPI 1730178104 · APO, AE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,567 in 74 payments from 13 companies in 2025. Trend: 2023 $1,031 · 2024 $1,457 · 2025 $1,567

Food & beverage: $1,567
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$290
Otsuka America Pharmaceutical, Inc.12$256
Janssen Pharmaceuticals, Inc5$225
Axsome Therapeutics, Inc.14$193
Corium, LLC9$180
ABBVIE INC.6$114
Tris Pharma Inc3$59
Bausch Health US, LLC3$55
Takeda Pharmaceuticals U.S.A., Inc.2$48
Collegium Pharmaceutical, Inc.2$44

Products named: CAPLYTA, SPRAVATO, Auvelity, Azstarys, REXULTI, VRAYLAR, Dyanavel XR, APLENZIN.

Industry payments across AE — which companies pay providers there.